Abstract | OBJECTIVE: STUDY DESIGN: Gestation day 18 pregnant rats were (1) treated with LPS (100 microg/kg, body weight; intraperitoneally) alone; (2) pretreated with NAC (300 mg/kg body weight; intraperitoneally) 30 minutes before LPS; (3) posttreated with NAC 120 minutes after LPS; or (4) treated with NAC 30 minutes before and 120 minutes after LPS. Six hours after LPS administration, maternal serum and amniotic fluid interleukin-6 (IL-6) and IL-10 levels, and placental IL-6 messenger RNA levels were determined. RESULTS: LPS increased maternal serum IL-6 (50 +/- 25 to 3444 +/- 584 pg/mL) and IL-10 (40 +/- 20 to 958 +/- 339 pg/mL) and amniotic fluid IL-6 (59 +/- 25 to 891 +/- 128 pg/mL). Pretreatment and/or posttreatment with NAC attenuated IL-6 in the maternal serum and amniotic fluid and IL-10 in the amniotic fluid. LPS also induced placental IL-6 messenger RNA that was inhibited by treatment with NAC before and after LPS. CONCLUSION: NAC inhibition of inflammatory responses may protect the fetus from potential long-term sequelae.
|
Authors | Ron Beloosesky, Dave A Gayle, Fataneh Amidi, Sonia E Nunez, Jooby Babu, Mina Desai, Michael G Ross |
Journal | American journal of obstetrics and gynecology
(Am J Obstet Gynecol)
Vol. 194
Issue 1
Pg. 268-73
(Jan 2006)
ISSN: 1097-6868 [Electronic] United States |
PMID | 16389042
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Antioxidants
- Cytokines
- Inflammation Mediators
- Interleukin-6
- Lipopolysaccharides
- RNA, Messenger
- Interleukin-10
- Acetylcysteine
|
Topics |
- Acetylcysteine
(pharmacology)
- Amniotic Fluid
(metabolism)
- Animals
- Antioxidants
(pharmacology)
- Cytokines
(antagonists & inhibitors)
- Female
- Inflammation Mediators
(antagonists & inhibitors)
- Interleukin-10
(blood)
- Interleukin-6
(blood, genetics, metabolism)
- Lipopolysaccharides
(pharmacology)
- Placenta
(metabolism)
- Pregnancy
- RNA, Messenger
(antagonists & inhibitors, metabolism)
- Rats
- Rats, Sprague-Dawley
|